Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-sequencing assay to identify changed gene expression in lung adenocarcinoma (LUAD) cells before and after osimertinib resistance

ABSTRACT: RNA-sequencing assay to identify changed gene expression in lung adenocarcinoma (LUAD) cells before and after osimertinib resistance

PROVIDER: PRJNA1135239 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29817000_1.fastq.gz	Fastqsanger.gz
	SRR29817000_2.fastq.gz	Fastqsanger.gz
	SRR29817001_1.fastq.gz	Fastqsanger.gz
	SRR29817001_2.fastq.gz	Fastqsanger.gz
	SRR29817002_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNA-sequencing assay to identify changed gene expression in lung adenocarcinoma (LUAD) cells before and after osimertinib resistance

Project description:The H1975 osimertinib resistant (H1975 OR) cell lines were successfully established by subjecting parental H1975 cells to a gradually increasing concentration of osimertinib up to 1μM for a duration exceeding 2 months. In order to investigate the molecular alterations associated with osimertinib resistance, we analyzed the transcriptional profiling of parental H1975 cells and H1975 OR cells by RNA sequencing.

2024-08-01 | GSE272162 | GEO

The differential gene expression of the lung cancer cell line HCC827 before and after resistance to osimertinib

Project description:Osimertinib, as a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), has been approved as a first-line therapy in advanced non–small-cell lung cancer (NSCLC) patients with EGFR-activating or T790M resistance mutations. However, the efficacy of osimertinib is limited due to acquired resistance. In order to search for the mechanism of resistance to osimertinib, we screened on significantly upregulated genes encoding protein kinases in osimertinib-resistant NSCLC cells via RNA-sequence.In summary, our data elucidate the alterations in gene expression within lung cancer cells before and after resistance to osimertinib, aiding in the analysis and identification of key molecules influencing osimertinib resistance.

2024-03-30 | GSE262582 | GEO

Circ101093 regulated proteins in Lung carcinoma (LUAD) cells.

Project description:Circ101093 was knocked down in A549 LUAD cell lines, and overexpressed in H1975 LUAD cell lines. Then, downregulated proteins in A549 cell lines and upregulated proteins in H1975 cell lines were analyzed.

2022-05-20 | PXD025491 | Pride

Different expressed genes beween osimertinib-treated and control group

Project description:Mice treated with osimertinib appeared skin problems. By comparing osimertinib group and control group, mechanisms were identified.

2024-12-31 | GSE272508 | GEO

Expression data of osimertinib tolerant H1975 cells

Project description:Even after osimertinib is administered to lung adenocarcinomas with EGFR mutations, there are a few cells which survive, and these tolerant cells are considered to be the source of later recurrence. We used microarray analysis to explore the mechanism behind the tolerance to osimertinib in lung adenocarcinoma cells with EGFR mutations.

2022-04-16 | GSE200893 | GEO

RNA-sequencing assay to Identify changed gene expression in gastric cancer cells with SCAMP1 knockdown

Project description:RNA-sequencing assay to Identify changed gene expression in gastric cancer cells with SCAMP1 knockdown

| PRJNA1061110 | ENA

iTRAQ experiment to identify proteins that changed before and after NMT1 was knocked down in both Bel-7402 and Bel-7404 cells

Project description:We performed proteomics isobaric tags for relative and absolute quantification (iTraq) to identify proteins that changed before and after NMT1 was knocked down in both Bel-7402 and Bel-7404 cells.

2021-09-08 | PXD011812 | Pride

Expression data of osimertinib tolerant PC-9 cells

2022-04-16 | GSE200894 | GEO

Osimertinib resistant cells of H1975

Project description:To tentatively explored the latent roles of miRNAs in Osimertinib treatment response and tried to explore the methylation related miRNA maturation in the generation of resistance

2021-09-30 | GSE184980 | GEO

RNA-sequencing assay to Identify changed gene expression in stomach adenocarcinoma (STAD) cells with ACAT2 knockdown

Project description:RNA-sequencing assay to Identify changed gene expression in stomach adenocarcinoma (STAD) cells with ACAT2 knockdown

| PRJNA1033647 | ENA